Back to top
more

PetMed Express (PETS)

(Real Time Quote from BATS)

$2.69 USD

2.69
28,527

+0.03 (1.13%)

Updated Sep 24, 2025 12:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 246)

Industry: Internet - Commerce

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

BioTelemetry (BEAT) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

BioTelemetry (BEAT) sees strong Q4 results, courtesy of solid acquisitions and promising performance by the MCT platform.

    Zacks Equity Research

    eBay's (EBAY) Marketplace is Expected to Do Well in 2018

    by Zacks Equity Research

    eBay (EBAY) is making all efforts to improve its Marketplace business.

      Zacks Equity Research

      JD.com (JD) Q4 Earnings Miss Estimates, Revenues Improve Y/Y

      by Zacks Equity Research

      JD.com's (JD) fourth-quarter earnings are impacted by higher spending in growth areas including fulfillment centers and increasing competition from Alibaba.

        Zacks Equity Research

        Bio-Rad (BIO) Q4 Earnings Improve Y/Y, Revenues Top Mark

        by Zacks Equity Research

        Bio-Rad's (BIO) strong sales in Q4 ride high on a robust performance at Life Science product lines.

          Zacks Equity Research

          OPKO Health (OPK) Q4 Earnings Decline Y/Y, Margins Down

          by Zacks Equity Research

          OPKO Health (OPK) posts lackluster Q4 numbers due to rising operating expenses owing to investments associated with the launch of RAYALDEE and consistent investments in the pharmaceutical pipeline.

            Zacks Equity Research

            DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q4

            by Zacks Equity Research

            Strong performance at Dental & Healthcare Consumables segment drives DENTSPLY's (XRAY) Q4 sales.

              Zacks Equity Research

              Patterson Companies (PDCO) Misses on Q3 Earnings, Cuts View

              by Zacks Equity Research

              Lower sales and gross-margin compression mars Patterson Companies' (PDCO) results in Q3.

                Zacks Equity Research

                Alarm.com (ALRM) Q4 Earnings Top Estimates, Issues 2018 View

                by Zacks Equity Research

                Alarm.com (ALRM) reports strong fourth-quarter results on the back of higher SaaS and license revenues, and portfolio expansion.

                  Zacks Equity Research

                  Masimo (MASI) Beats on Q4 Earnings & Revenues, View Positive

                  by Zacks Equity Research

                  Strong performance in Product revenues drove Masimo's (MASI) fourth-quarter 2017 results.

                    Zacks Equity Research

                    DexCom (DXCM) Surpasses Earnings & Revenue Estimates in Q4

                    by Zacks Equity Research

                    DexCom (DXCM) rides high on strength in all segments in Q4.

                      Zacks Equity Research

                      Wright Medical (WMGI) Beats Q4 Earnings & Revenue Estimates

                      by Zacks Equity Research

                      Wright Medical (WMGI) delivers promising Q4 results on the back of strength in its flagship Upper Extremities segment, despite declining international revenues of the Lower Extremities.

                        Zacks Equity Research

                        Amedisys (AMED) Q4 Earnings Miss, Revenues Beat Estimates

                        by Zacks Equity Research

                        Amedisys (AMED) registers strong growth across all segments in Q4.

                          Zacks Equity Research

                          Penumbra (PEN) Posts Earnings in Q4, Revenues Top Estimates

                          by Zacks Equity Research

                          Penumbra (PEN) sees strong growth across all geographical regions and product lines in Q4.

                            Zacks Equity Research

                            Inogen (INGN) Beats Earnings and Revenue Estimates in Q4

                            by Zacks Equity Research

                            Inogen (INGN) reports impressive Q4 financial results on the back of strong business-to-business and direct-to-consumer sales growth.

                              Zacks Equity Research

                              Integra LifeSciences (IART) Beats on Q4 Earnings & Revenues

                              by Zacks Equity Research

                              Integra LifeSciences's (IART) solid Q4 revenue growth was primarily driven by high organic revenues and better-than-expected performance by the recently-acquired businesses.

                                Zacks Equity Research

                                Booking Holdings (BKNG) Beats on Q4 Earnings & Revenues

                                by Zacks Equity Research

                                Booking Holdings' (BKNG) fourth-quarter results are driven by significant contributions from investments in people, systems and marketing.

                                  Zacks Equity Research

                                  Fitbit (FIT) Q4 Loss Greater Than Estimated, Revenues Miss

                                  by Zacks Equity Research

                                  Fitbit's (FIT) fourth-quarter 2017 results are impacted by weak demand for its fitness products.

                                    Zacks Equity Research

                                    NuVasive (NUVA) Meets Q4 Earnings Estimates, Issues '18 View

                                    by Zacks Equity Research

                                    NuVasive (NUVA) gains on continued growth in international business in Q4.

                                      Zacks Equity Research

                                      PetMed (PET) Focuses on Advertising to Boost New Order Sales

                                      by Zacks Equity Research

                                      PetMed (PETS) implements several strategies to revitalize top line.

                                        Zacks Equity Research

                                        GoDaddy (GDDY) Beats Earnings & Revenue Estimates in Q4

                                        by Zacks Equity Research

                                        GoDaddy (GDDY) reports strong fourth-quarter revenues on the back of growth in customers, new products and contribution from HEG acquisition.

                                          Ryan McQueeney headshot

                                          After Wayfair's Earnings Miss, Buy These E-Commerce Stocks Instead

                                          by Ryan McQueeney

                                          Shares of Wayfair (W) were down more than 17% in early morning trading Thursday after the e-commerce company posted a wider-than-expected fourth-quarter loss. For investors who would rather focus on e-commerce stocks that have recently posted positive earnings surprises, there are plenty of options elsewhere.

                                            Ryan McQueeney headshot

                                            3 Retail Stocks That Crushed Earnings Estimates This Season

                                            by Ryan McQueeney

                                            The holiday season has the potential to make or break of retailer's fiscal year. Now that we are on the other side of the bulk of Q4's earnings announcements, we can see that several notable companies performed particularly well.

                                              Zacks Equity Research

                                              Garmin (GRMN) Q4 Earnings Beat Estimates, Issues 2018 View

                                              by Zacks Equity Research

                                              Garmin (GRMN) delivers strong fourth-quarter results on the back of solid performance in fitness, marine, outdoor and aviation segments.

                                                Zacks Equity Research

                                                Why Is PetMed Express (PETS) Down 9.8% Since the Last Earnings Report?

                                                by Zacks Equity Research

                                                PetMed Express (PETS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                                  Zacks Equity Research

                                                  Ecolab (ECL) Misses Q4 Earnings Estimates, View Impressive

                                                  by Zacks Equity Research

                                                  Despite strength in Global Industrial and Global Institutional segments, Ecolab (ECL) ended the fourth quarter on an unfavorable note.